Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00170170 · ClinicalTrials.gov registry record

Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
500
Enrollment target

NCT00170170: Completed study, sponsored by Mayo Clinic.

NCT00170170 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00170170 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
500 participants
Enrollment target

Study Summary

This study will investigate the clinical variables that may be used to predict who among the solid organ transplant recipients will develop cytomegalovirus (CMV) disease after completing antiviral prophylaxis.

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2004-11
Est. Completion 2007-06
Mayo Clinic

2,844 total trials

What the finished NCT00170170 record still lists

NCT00170170 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00170170 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00170170 about?

NCT00170170 is a clinical study titled "Risk Factors for Cytomegalovirus Disease in Solid Organ Transplantation". This study will investigate the clinical variables that may be used to predict who among the solid organ transplant recipients will develop cytomegalovirus (CMV) disease after completing antiviral prophylaxis.

What is the current status of trial NCT00170170?

This trial is currently completed. The enrollment target is 500 participants. The study started on 2004-11. Estimated completion is 2007-06.

Who is sponsoring clinical trial NCT00170170?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001230 · 500 participants

    Host Response to Infection and Treatment in Filarial Diseases

  • NCT00001529 · 500 participants

    Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

  • NCT00697411 · 500 participants

    Study of Selected X-Linked Disorders: Aicardi Syndrome

  • NCT00903110 · 500 participants

    Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00170170, the US trial registry maintained by the National Library of Medicine. NCT00170170 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.